Losmapimod Safety and Efficacy in COVID-19
Clinical trial NCT04511819 · TERMINATED
Trial details
- NCT number
- NCT04511819
- Sponsor
- Fulcrum Therapeutics
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-28
- Primary completion
- 2021-03-31
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.